Clinical Recruitment Growth Antidote Technologies specializes in connecting patients and researchers for clinical studies, positioned to expand its recruiter capabilities across more therapeutic areas and trial formats, suggesting opportunities to partner with CROs and pharma companies seeking efficient trial recruitment solutions.

Strategic Partnerships Recent collaborations with Seqster, Beyond Type 1, and JDRF indicate a proven model for integrating patient engagement platforms with research recruitment, presenting a sales angle to enterprise customers seeking integrated patient-centric ecosystems.

Security and Compliance With CyberGRX risk assessment completion and a tech stack emphasizing data governance tools like OneTrust and DocuSign, there is a strong basis to target organizations prioritizing vendor risk management and data privacy in clinical trials.

Global Footprint Headquartered in New York and London with impact in multiple regions, Antidote’s international presence supports pursuing multinational trials and cross-border patient recruitment initiatives for global pharmaceutical programs.

Sustainability and Recognition EcoVadis Silver Award and a 2024 Improving Lives Benefit Corporate Honoree showcase a commitment to responsible business practices, which can resonate with ESG-focused sponsors seeking vendors with credible sustainability credentials.